FDA Receives Upadacitinib Application for Ankylosing Spondylitis & Approves Tramadol Hydrochloride Oral Solution

In August, Abbvie submitted a new drug application for upadacitinib to treat ankylosing spondylitis. And in September, the FDA approved an oral solution of tramadol hydrochloride for pain.

Source: The Rheumatologist - September 30, 2020 Category: Rheumatology Authors: Michele B. Kaufman, PharmD, BCGP Tags: Drug Updates ankylosing spondyl­itis Ankylosing spondylitis (AS) FDA Pain Pain Management tramadol hydrochloride U.S. Food and Drug Administration (FDA) upadacitinib Source Type: research